Status:
COMPLETED
Effect of the Extract of the Flour Fermented With Bacillus Subtilis Var Natto DC-15 on Postprandial Glucose
Lead Sponsor:
Hiroshima University
Collaborating Sponsors:
NewBio Enterprise Co., ltd.
Conditions:
Prediabetes
Eligibility:
All Genders
35-70 years
Phase:
NA
Brief Summary
The purpose of the present study is to evaluate the effect of the extract of the flour fermented with Bacillus subtilis var natto DC-15 on postprandial glucose level in subjects with prediabetes.
Eligibility Criteria
Inclusion
- Fasting plasma glucose 110-125 mg/dL
Exclusion
- Taking anti-diabetic drugs
- Taking drugs or functional food that may affect blood glucose level
- Pregnant or nursing a child
- Participation in any clinical trial within 90 days of the commencement of the trial
- Renal or hepatic dysfunction
- Heart disease
- History of severe disease and/or major surgery
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02300181
Start Date
October 1 2014
End Date
March 1 2015
Last Update
August 19 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hiroshima University
Hiroshima, Japan, 734-8551